Chemotherapeutics as Immune Modulators for the Treatment of Triple-Negative Breast Cancer. [PDF]
Fines CB +3 more
europepmc +1 more source
ABSTRACT Extracellular vesicles (EVs) are central mediators of tumour‐stroma communication, yet the mechanisms governing their biogenesis and functional cargo remain poorly understood. Here, we identify CD133 (Prominin‐1), selectively expressed in basal‐like triple‐negative breast cancer (BL‐TNBC) cells, acts as a key organizer of EV production and ...
Mireia Gomez‐Duro +14 more
wiley +1 more source
Konjac petroleum ether extract inhibits triple-negative breast cancer cell migration and invasion by attenuating <i>OLFML2A</i>-mediated epithelial-mesenchymal transition. [PDF]
Chen Y, Yu Q, Ding H, Jiang W, Gao X.
europepmc +1 more source
Igniting cold tumors: reprogramming the tumor immune microenvironment with dual-payload ADCs in combination with PD-L1&4-1BB bispecific antibodies. [PDF]
Pan J +12 more
europepmc +1 more source
Social disparities in the frequency and severity of triple-negative breast cancer at diagnosis in a university hospital in Paris, France: confronting race and ethnic blindness. [PDF]
Chauvin P +3 more
europepmc +1 more source
Effects of SOX10 on the proliferative, invasive, migratory, and epithelial-mesenchymal transition abilities of triple-negative breast cancer cells. [PDF]
Wang S, Jin L.
europepmc +1 more source
Glucose metabolic reprogramming: a novel strategy to enhance radiotherapy response to triple-negative breast cancer. [PDF]
Gan L +6 more
europepmc +1 more source
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies. [PDF]
Ortega-Álvarez D +21 more
europepmc +1 more source

